To characterize platelets in patients with breast cancer, we compared CD62P expression levels, platelet aggregation, and the release function of platelets from breast cancer patients and benign patients using flow cytometry, platelet aggregation assays, and ATP secretion detection, respectively. This evidence concerns the gene SELP and breast cancer.